Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023
A 30-Year-Old Woman Presenting with Rapidly Progressive Dementia and Extreme Hypoglycorrhachia
Neurol 102:e209188, Bai,X.,et al, 2024
Diagnosis and Management of Cerebral Venous Thrombosis:A Scientific Statement From the American Heart Association
Stroke 55:e77-e90, Saposnik,G.,et al, 2024
Stroke Education in the Digital Era:Recent Advances and the E-Strategy of the World Stroke Academy
Stroke 55:e52-e55, Guerrero,R.,et al, 2024
Advances in Cerebral Venous Thrombosis
Stroke 55:2169-2172, deSousa,D.A. & Neto,L.L., 2024
Fewer COVID-19 Neurological Complications with Dexamethasone and Remdesivir
Ann Neurol 93:88-102, Grundmann,A.,et al, 2023
Prognosis and Persistence of Smell and Taste Dysfunction in Patients with covid-19: Meta-Analysis with Parametric Cure Modelling of Recovery Curves
BMJ 378:e0695031, Tan, B.K.J.,et al, 2022
Clinicopathologic Conference, Cotards Syndrome, Catatonia, Depression and Coronavirus Disease 2019
NEJM 387:1795-1802, , 2022
Clinical Manifestation,Management,and Outcomes in Patients with COVID-19 Vaccine-Induced Acute Encephalitis:Two Case Reports and a Literature Review
Vaccines 10:1230, Shyu,S.,et al, 2022
COVID-19-Booster Vaccine-Induced Encephalitis
Acta Neurol Belg 122:579-581, Sluyts,Y.,et al, 2022
Pseudotumor Cerebri Syndrome with COVID-19: A Case Series
J Neuro Ophthalmol 42:e545-e547, Mukharesh,L.,et al, 2022
Three Territory Sign in COVID-19
Acta Neurol Belg doi.10.1007/s13760-021-01842-8, Bhatele, P.,et al, 2022
Multisystem Involvement in Post-Acute Sequelae of Coronavirus Disease 19
Ann Neurol 91:367-379, Novak, P.,et al, 2022
Global Teleneurology
Ann Neurol 91:443-444, , 2022
Neurological Events Reported after COVID-19 Vaccines: An Analysis of Vaccine Adverse Event Reporting System
Ann Neurol 91:756-771, Frontera, J.A.,et al, 2022
Changes in Stroke Hospital Care During the COVID-19 Pandemic
Stroke 52:3651-3660, Katsanos, A.H.,et al, 2021
ANA Investigates: Neurological Complications of Covid-19 Vaccines
Ann Neurol 89:856-857, Goss, A.L.,et al, 2021
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for Covid-19 or Multisystem Inflammatory Syndrome
JAMA Neurol 78:536-547, LaRovere, K.L.,et al, 2021
Helping with Public Understand Adverse Events Associated with Covid-19 Vaccinations
JAMA Neurol 78:789-790, Kim, D.D.,et al, 2021
COVID-19 Associated Myelitis Involving the Dorsal and Lateral White Matter Tracts
AJNR 42:1912-1917, Huang, H.Y.,et al, 2021
Digital Health
Stroke 52:351-355, Silva, G.S. & Schwamm, L.H., 2021
Pediatric Parainfectious Encephalitis Associated with COVID-19
Neurol 96:541-544, Gaughan, M.,et al, 2021
Bilateral Superior Ophthalmic Vein Thrombosis, Ischaemic Stroke, and Immune Thrombocytopenia After ChAdOx1 nCoV-19 Vaccination
Lancet 397:e11, Bayas, A.,et al, 2021
Encephalopathies Associated with Severe COVID-19 Present Neurovascular Unit Alterations without Evidence for Strong Neuroinflammation
Neurol Neuroimmunol Neuroinflamm 8:e1029, Bernard-Valnet, R.,et al, 2021
Isolated Intracranial Hypertension Associated with COVID-19
Cephalagia 40:1452-1458, Tulius,M.,et al, 2020
A case of COVID-19-associated pharyngeal-cervical-brachial variant of Guillain-Barre syndrome
Neurol 95:978-983, Liberatore, G.,et al, 2020
Guillain-Barre Syndrome Associated with SARS-CoV-2
NEJM 382:2574-2576, Tuscano, G.,et al, 2020
Covd-19-Associated Myopathy Caused by Type 1 Interferonopathy
NEJM 383:2389-2390, Manzano, A.C.,et al, 2020
COVID-19-Associated PRES-like Encephalopathy with Perivascular Gadolinium Enhancement
AJNR 41:2206-2208, Conte, G.,et al, 2020
COVID-19 is Catalyzing the Adoption of Teleneurology
Neurol 94:903-904, Klein, B.C. & Busis, N.A., 2020
Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19
JAMA Otolaryngology Head Neck Surg doi:10.1001/JAMAOTO.2020.0832, Elieyer, M.,et al, 2020
Neurologic Features in Severe SARS-CoV-2 Infection
NEJM 382:2268-2270, e110, , 2020
Alterations in Smell or Taste in Mildly Symptomatic Outpatients with SARS - CoV-2 Infection
JAMA 323:2089-2090, Spinato, G.,et al, 2020
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
NEJM 382:e38, Zhang, Y.,et al, 2020
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
NEJM 382:e61-e63, Oxley, T.J., et al, 2020
Neurologic Complications of Coronavirus Infections
Neurol 94:809-810, Nath, A., 2020
Preparing a Neurology Department for SARS-CoV-2 (COVID-19)
Neurol 94:886-891, Waldman, G.,et al, 2020
Olfactory Dysfunction in COVID-19
JAMA doi:10.1001/JAMA.2020.8391, Whitcroft, K.L. & Hummel, T., 2020
Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams
Stroke 51:1896-1901, Nguyen, T.N.,et al, 2020
Protected Code Stroke
Stroke 51:1891-1895, Khosravani, H.,et al, 2020
The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection
JAMA Neurol 77:679-680, Pleasure, S.J.,et al, 2020
Teleneurology
Pract Neurol 19:13, Gollomp, S. & Mathew, P.G., 2020
Training in Neurology: Flexibility and Adaptability of a Neurology Training Program at the Epicenter of COVID-19
Neurol 94:e2608-e2614, Agarwal, S.,et al, 2020
Rapid Implementation of Virtual Neurology in Response to the COVID-19 Pandemic
Neurol 94:1077-1087, Grossman, S.N.,et al, 2020
Neuropathological Features of Covid-19
NEJM doi:10.1056/NEJMc2019373, Solomon, I.H.,et al, 2020
Early Evidence of Pronounced Brain Involvement in Fatal COVID-19 outcomes
Lancet 395:e109, von Weyhern, C.H.,et al, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Ischemic Stroke
Stroke 51:e124-e127, Valdes Valderrama, E.,et al, 2020
COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020
CT Scanning in Suspected Stroke or Head Trauma: Is It Worth Going the Extra Mile and Including the Chest to Screen for COVID-19 Infection?
AJNR 41:1165-1169, Kwee, R.M.,et al, 2020